NEOMEDICAL signs exclusive marketing venture with BARD SA (Pty) Ltd

NEOMEDICAL has signed an exclusive marketing deal with the prestigious multinational medical device company, BARD SA. The deal authorises NEOMEDICAL to market three superior quality product lines in respective territories with in South Africa. The products are drawn from the latest generation in haemostasis from Bard and fixation devices of the portfolio of BARD ACCESS. These include; Arista™ AH Absorbable Haemostatic Particles, Avitene™ Microfibrillar Collagen Haemostat and STATLOCK® IV Universal Stabilization Devices.

NEOMEDICAL offers BARD SA a dedicated marketing force, as well as endorsing the high corporate standards to which BARD SA aspires. We look forward to the opportunity this collaboration represents to both companies and the value add benefits that the venture will bring to the healthcare community in South Africa.